End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
16.34 CNY | +0.25% | -1.03% | +11.61% |
Apr. 23 | Cisen Pharmaceutical Names Chief Financial Officer | MT |
Apr. 22 | Cisen Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Sales 2022 | 4.07B 563M | Sales 2023 | 4.46B 618M | Capitalization | 6.6B 914M |
---|---|---|---|---|---|
Net income 2022 | 350M 48.46M | Net income 2023 | 521M 72.13M | EV / Sales 2022 | 0.75 x |
Net cash position 2022 | 2.63B 363M | Net cash position 2023 | 2.6B 361M | EV / Sales 2023 | 0.9 x |
P/E ratio 2022 |
16.4
x | P/E ratio 2023 |
12.7
x | Employees | 3,402 |
Yield 2022 |
2.66% | Yield 2023 |
2.98% | Free-Float | 37.4% |
1 day | +0.25% | ||
1 week | -1.03% | ||
Current month | +1.93% | ||
1 month | +9.08% | ||
3 months | +20.24% | ||
6 months | +15.23% | ||
Current year | +11.61% |
Managers | Title | Age | Since |
---|---|---|---|
Zhen Xin Du
CEO | Chief Executive Officer | 57 | 98-11-05 |
En Long Zhao
CHM | Chairman | 45 | 04-06-30 |
Xin Bang Xu
DFI | Director of Finance/CFO | 46 | 00-07-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Hong Zhang
BRD | Director/Board Member | 59 | 17-11-27 |
Zhen Xin Du
CEO | Chief Executive Officer | 57 | 98-11-05 |
Hong Cai
BRD | Director/Board Member | 63 | 20-12-07 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-17 | 16.34 | +0.25% | 2,826,855 |
24-05-16 | 16.3 | -0.97% | 3,109,000 |
24-05-15 | 16.46 | -0.96% | 2,825,115 |
24-05-14 | 16.62 | +0.12% | 3,496,884 |
24-05-13 | 16.6 | +0.55% | 5,546,628 |
End-of-day quote Shanghai S.E., May 16, 2024
More quotes1st Jan change | Capi. | |
---|---|---|
+11.61% | 1.02B | |
+21.63% | 44.11B | |
+23.03% | 22.71B | |
+18.22% | 15.15B | |
+12.66% | 13.56B | |
+60.18% | 12.7B | |
-10.02% | 6.84B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+12.92% | 5.63B |
- Stock Market
- Equities
- 603367 Stock